Active, Not Recruiting
Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
NCT04479267
- Conditions
- Diffuse Large B-cell Lymphoma, Double Expressor Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States